How many days should Cardiotocography (CTG) monitoring be done in a baby with Intrauterine Growth Restriction (IUGR), is it 3 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiotocography (CTG) Monitoring in IUGR Babies

For babies with Intrauterine Growth Restriction (IUGR), cardiotocography (CTG) monitoring should be performed at least twice weekly, with increased frequency to 2-3 times per week when IUGR is complicated by absent or reversed end-diastolic flow in the umbilical artery. 1, 2

Monitoring Frequency Based on IUGR Severity

The frequency of CTG monitoring depends on the severity of IUGR and umbilical artery Doppler findings:

Normal Umbilical Artery Doppler

  • Weekly CTG monitoring after fetal viability 2
  • Twice weekly nonstress testing with weekly amniotic fluid evaluation 1
  • Consider delivery at 38-39 weeks 1

Decreased End-Diastolic Flow

  • Increase frequency of testing 1
  • Consider delivery at >37 weeks 1

Absent End-Diastolic Flow (AEDV)

  • CTG monitoring 2-3 times per week 1, 2
  • Consider delivery at >34 weeks 1

Reversed End-Diastolic Flow (REDV)

  • Daily CTG monitoring (1-2 times per day) 2
  • Hospitalization recommended 2
  • Consider delivery at >32 weeks 1

Additional Considerations

  • Hospitalization may be offered when fetal testing more than 3 times per week is deemed necessary 1
  • The combination of ultrasound and cardiotographic surveillance techniques has been shown to improve outcomes for IUGR fetuses 1
  • For very early gestational age IUGR (e.g., at 25 weeks) with absent or reversed end-diastolic flow, aggressive interventions may be deferred given the poor prognosis 1

Important Monitoring Nuances

  • Early-onset IUGR (<32 weeks) differs from late-onset IUGR (≥32 weeks) in monitoring approach 3:

    • Early-onset: Focus on venous Doppler parameters and computerized CTG
    • Late-onset: Focus on cerebral Doppler parameters
  • Computerized CTG (cCTG) is particularly useful for evaluating chronic hypoxemia in IUGR fetuses 4

  • Parameters that help distinguish between IUGR and healthy fetuses before 36 weeks include fetal heart rate baseline, short-term variability, long-term irregularity, and delta 4

Clinical Pitfalls to Avoid

  • Don't rely solely on CTG monitoring; integrate with fetal ultrasound and Doppler vessel evaluation to better predict neonatal outcomes 4
  • Don't use the same monitoring protocol for early-onset and late-onset IUGR as they have different pathophysiology and progression patterns 3
  • Don't delay corticosteroid administration when indicated (absent or reversed end-diastolic flow at <34 weeks), but ensure close observation for 48-72 hours afterward due to potential increased physiologic demands 1

Remember that the goal of monitoring is to balance the risks of prematurity against the risks of continued intrauterine stay in a compromised environment, with the ultimate aim of reducing perinatal morbidity and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fetal Growth Restriction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

When should ultrasound monitoring start for a fetus with suspected Intrauterine Growth Restriction (IUGR)?
What is the most appropriate next step in management for a 19-year-old primigravida (first-time pregnant woman) at 38 weeks gestation with intrauterine growth restriction (IUGR), meconium-stained amniotic fluid, and abnormal cardiotocography (CTG) findings showing fetal distress?
24‑year‑old primigravida at 35 weeks gestation (by LMP) with low‑normal fundal height, estimated fetal weight in the 10‑12th percentile (suspected intra‑uterine growth restriction/small for gestational age), history of polycystic ovarian syndrome, BMI 24.7 kg/m², bacterial vaginosis on pap smear, and asymptomatic bacteriuria with Pseudomonas fluorescens—what is the obstetric diagnosis and what diagnostic, therapeutic, birth, and postpartum management plans should be implemented, including three differential diagnoses with rationale?
What is the recommended nutrition and management plan to achieve catch‑up growth in an infant born with intrauterine growth restriction (IUGR)?
For how many days should capillary blood glucose monitoring be done in an Intrauterine Growth Restriction (IUGR) baby?
What is the recommended treatment approach for patients presenting with functional dyspepsia symptoms?
What are the diagnostic and treatment approaches for pediatric patients presenting with symptoms suggestive of bone tumors?
For how many days should capillary blood glucose monitoring be done in an Intrauterine Growth Restriction (IUGR) baby?
What is the recommended oral (PO) dose of oxycodone for a 15-year-old patient weighing 60kg?
What is the initial management for full inpatient treatment of hypertensive urgency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.